BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7653278)

  • 1. Hepatitis C virus antibodies in asymptomatic chronic carriers of hepatitis B surface antigen.
    Barros H; Miranda HP; Silvestre F
    Acta Med Port; 1994 Dec; 7 Suppl 1():S30-4. PubMed ID: 7653278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis C virus infection in chronic asymptomatic carriers of HBs antigen].
    Barros H; Miranda HP; Silvestre F
    Acta Med Port; 1993 Feb; 6(2):75-7. PubMed ID: 8488765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
    Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
    Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HCV and HBV seropositivity in university students of the State of Nuevo Leòn, Mexico].
    Flores-Castañeda MS; García-Méndez BL; Tijerina-Menchaca R
    Rev Gastroenterol Mex; 1996; 61(4):327-31. PubMed ID: 9072784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of hepatitis D virus infection in chronic hepatitis B virus carriers].
    Hacibektaşoğlu A; Barut A; Inal A
    Mikrobiyol Bul; 1992 Jul; 26(3):224-32. PubMed ID: 1528142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood donors with positive HBsAg in Asturias: its current prevalence and significance].
    Suárez A; Riestra S; Navascués CA; Sotorrío NG; Rodríguez M; Tévar F; Pérez R; Sala P; Rodrigo L
    Med Clin (Barc); 1994 Mar; 102(9):329-32. PubMed ID: 8164459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.
    Ghavanini AA; Sabri MR
    East Mediterr Health J; 2000; 6(5-6):1114-6. PubMed ID: 12197336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibody to hepatitis C virus in chronic HBsAg carriers.
    Rodríguez M; Navascues CA; Martínez A; Suárez A; Riestra S; Sala P; González M; Rodrigo L
    Arch Virol Suppl; 1992; 4():327-8. PubMed ID: 1333329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection.
    Sheen IS; Liaw YF; Chu CM; Pao CC
    J Infect Dis; 1992 May; 165(5):831-4. PubMed ID: 1314869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
    Wang SP; Ding H; Zhao OK
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan.
    Chen CJ; Tseng SF; Lu CF; Lin HC; You SL; Chen CS; Hwang SJ; Hsieh SF; Hsu ST
    J Med Virol; 1992 Oct; 38(2):97-101. PubMed ID: 1460460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B and delta: the prevalence of seroepidemiological markers in volunteer blood donors and their families].
    Alvarez-Muñoz MT; Bustamante-Calvillo ME; Guiscafré-Gallardo JP; Muñoz O
    Gac Med Mex; 1991; 127(5):399-404. PubMed ID: 1790848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatitis C in central Portugal. Prevalence of anti-HCV in the population of the Coimbra District.
    Santos A; Carvalho A; Bento D; Sá R; Tomáz J; Rodrigues V; Pais L; Porto A
    Acta Med Port; 1994 Dec; 7 Suppl 1():S3-8. PubMed ID: 7653277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
    Kuperan P; Choon AT; Ding SH; Lee G
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.